Published in Am J Cardiol on November 01, 1982
Reduction of infarct size. An attractive concept: useful--or possible--in humans? Br Heart J (1985) 0.87
High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis. Br Heart J (1986) 0.86
Asynchronous left ventricular wall motion early after coronary thrombosis. Br Heart J (1986) 0.82
Initial clinical outcomes of intracoronary infusion of autologous progenitor cells in patients with acute myocardial infarction. ARYA Atheroscler (2012) 0.79
Thrombolytic therapy in acute myocardial infarction. A perspective. Drugs (1987) 0.76
Active management of myocardial infarction. Br Med J (Clin Res Ed) (1983) 0.76
Determinants of infarct size in patients successfully treated by intracoronary thrombolysis. Tex Heart Inst J (1984) 0.75
Intravenous short-term infusion of streptokinase in acute myocardial infarction. Tex Heart Inst J (1984) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med (2002) 12.84
A physical map of the human genome. Nature (2001) 12.39
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med (1985) 11.14
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med (2001) 7.86
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell (1991) 7.29
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med (1987) 5.64
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med (1996) 5.29
Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med (1992) 5.03
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87
Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med (1988) 4.79
A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome. Nat Genet (2000) 4.78
Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med (2000) 4.43
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell (1994) 4.04
Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation (2003) 3.86
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods (1996) 3.80
Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J Exp Med (1986) 3.74
N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem (1999) 3.72
Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol (1996) 3.24
Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry (1992) 3.23
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods (1999) 3.09
Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science (1992) 3.05
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation (1998) 2.90
Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol (1998) 2.73
It's time for a change to a troponin standard. Circulation (2000) 2.69
Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene (2001) 2.67
Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol (1989) 2.63
MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol (2008) 2.55
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood (1999) 2.47
Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA (2000) 2.29
Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation (2001) 2.28
Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol (1981) 2.28
Sacral nerve stimulation in patients with severe constipation. Dis Colon Rectum (2008) 2.25
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol (2000) 2.24
Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol (2000) 2.24
Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med (1990) 2.21
Expression of Thy-1 antigen by murine epidermal cells. J Invest Dermatol (1983) 2.20
Dendritic cells as vectors for therapy. Cell (2001) 2.18
Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J (2000) 2.16
Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest (1993) 2.16
Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci (1993) 2.15
Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol (1995) 2.11
Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol (1993) 2.10
Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci U S A (1991) 2.06
A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol (1993) 2.06
Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med (1993) 2.03
A radiation hybrid map of mouse genes. Nat Genet (2001) 2.03
The effect of aortic valve replacement on survival. Circulation (1982) 2.03
Extracellular invertase: key metabolic enzyme and PR protein. J Exp Bot (2003) 2.02
PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med (2001) 2.01
Acquired antibiotic resistance in lactic acid bacteria from food. Antonie Van Leeuwenhoek (1999) 1.97
The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells. J Exp Med (1985) 1.93
Troponin elevation in coronary vs. non-coronary disease. Eur Heart J (2010) 1.93
Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease. Clin Infect Dis (1999) 1.91
Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 1.86
Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med (1994) 1.75
Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging (2004) 1.71
The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system. Springer Semin Immunopathol (1992) 1.68
Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation (1981) 1.68
Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res (1993) 1.68
S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem (1991) 1.66
Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation (2001) 1.64
Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation (1995) 1.61
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood (1998) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease. J Am Coll Cardiol (1999) 1.58
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58
Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome X") Circulation (1989) 1.57
A comparison of murine epidermal Langerhans cells with spleen dendritic cells. J Invest Dermatol (1985) 1.57
Prevention of latex allergy by selection of low-allergen gloves. Clin Exp Allergy (2000) 1.55
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1. Clin Exp Allergy (2004) 1.55
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer (2001) 1.52
Regulation of glycolysis in the ischemic and the anoxic myocardium. J Mol Cell Cardiol (1970) 1.52
Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis. Eur Heart J (2002) 1.51
Antibiotic resistance spread in food. Nature (1997) 1.50
Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta (2011) 1.49
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation (1997) 1.48